Clearwater Analytics (CWAN) Sale Investigation: $24.55 Per Share Offer by Permira and Warburg Pincus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Source: PRnewswire
- Investigation Launched: Former Louisiana Attorney General Charles C. Foti and his law firm Kahn Swick & Foti are investigating Clearwater Analytics (CWAN)'s proposed sale to Permira and Warburg Pincus for $24.55 per share, aiming to assess the adequacy of the transaction.
- Shareholder Rights Concern: KSF seeks to determine whether the proposed sale undervalues Clearwater Analytics, and shareholders who believe this may contact KSF to discuss their legal rights and ensure their interests are protected.
- Legal Consultation Offered: KSF provides no-obligation legal consultation services, allowing shareholders to reach out via email or phone to KSF Managing Partner Lewis S. Kahn for more information regarding their rights in the transaction.
- Firm Background: Kahn Swick & Foti, led by a former Louisiana Attorney General, focuses on protecting shareholder rights and ensuring that shareholder interests are not overlooked in merger and acquisition transactions.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on CWAN
Wall Street analysts forecast CWAN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CWAN is 27.83 USD with a low forecast of 24.55 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 24.130
Low
24.55
Averages
27.83
High
36.00
Current: 24.130
Low
24.55
Averages
27.83
High
36.00
About CWAN
Clearwater Analytics Holdings, Inc. is a provider of comprehensive cloud-native platforms for institutional investors across global public and private markets. The Company’s single-instance, multi-tenant architecture delivers real-time data and artificial intelligence (AI)-driven insights throughout the investment lifecycle. The platform eliminates information silos by integrating portfolio management, trading, investment accounting, reconciliation, regulatory reporting, performance, compliance, and risk analytics in one unified system. The Company serves insurers, asset managers, hedge funds, banks, corporations, and governments. The Company is also a provider of enterprise risk analytics and developer infrastructure. Its capabilities in complex portfolio management across both public and private markets include structured products, private credit, and derivatives.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wall Street Analysts Adjust Ratings on Key Stocks
- Emerson Electric Downgrade: Oppenheimer analyst Christopher Glynn downgraded Emerson Electric Co (NYSE:EMR) from Outperform to Perform, reflecting market caution regarding its future growth, with shares closing at $149.13 on Monday.
- Skywater Technology Rating Change: Needham analyst N. Quinn Bolton downgraded Skywater Technology Inc (NASDAQ:SKYT) from Buy to Hold, indicating concerns about its short-term performance, as shares closed at $32.35 on Monday.
- Bitdeer Technologies Downgrade and Price Target Cut: Keefe, Bruyette & Woods analyst Stephen Glagola downgraded Bitdeer Technologies Group (NASDAQ:BTDR) from Outperform to Market Perform and cut the price target from $26.5 to $14, reflecting pessimism about its future profitability, with shares closing at $13.90 on Monday.
- Procter & Gamble Rating Adjustment: TD Cowen analyst Robert Moskow downgraded Procter & Gamble Co (NYSE:PG) from Buy to Hold, although raising the price target to $156, shares still closed at $149.49 on Monday, indicating market divergence regarding its growth potential.
Continue Reading
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
Continue Reading